# Efficacy and Safety Study of Nangibotide in Patients With COVID-19 Receiving Ventilatory Support

> **NCT04429334** · PHASE2 · COMPLETED · sponsor: **Inotrem** · enrollment: 220 (actual)

## Conditions studied

- COVID19

## Interventions

- **DRUG:** nangibotide
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT04429334
- **Lead sponsor:** Inotrem
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-23
- **Primary completion:** 2022-05-20
- **Final completion:** 2022-06-22
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2023-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04429334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04429334, "Efficacy and Safety Study of Nangibotide in Patients With COVID-19 Receiving Ventilatory Support". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04429334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*